(Q28580979)

31 January 2017

title

Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy (English)

1 reference

31 January 2017

0 references

1 reference

Atsuo Tahara

1

1 reference

31 January 2017

Junko Tsukada

2

1 reference

31 January 2017

Yuichi Tomura

3

1 reference

31 January 2017

Takeshi Suzuki

4

1 reference

31 January 2017

Takeyuki Yatsu

5

1 reference

31 January 2017

Masayuki Shibasaki

6

1 reference

31 January 2017

publication date

1 June 2007

1 reference

31 January 2017

published in

Vascular Pharmacology

1 reference

31 January 2017

volume

46

1 reference

31 January 2017

issue

6

1 reference

31 January 2017

page(s)

463–469

1 reference

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Arginine vasopressin stimulates human mesangial cell production of endothelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Role of vasopressin in the mitotic response of rat bone marrow cells to haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Endothelin receptor subtype B mediates autoinduction of endothelin-1 in rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response t

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Physiology of the mesangial cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Enhancement of [3H-Methyl]Thymidine Incorporation and Replication of Rat Chondrocytes Grown in Tissue Culture by Plasma, Tissue Extracts and Vasopressin1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Vasopressin stimulation of mouse 3T3 cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Interleukin 6 is an autocrine growth factor for mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Production of endothelin-1 by rat cultured mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Regulation of endothelin-1 production in cultured rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Binding and signal transduction characteristics of the nonpeptide vasopressin V1A receptor-selective antagonist YM218 in cultured rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Pharmacological characterization of YM471, a novel potent vasopressin V(1A) and V(2) receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

Synthesis and receptor specificities of vasopressin antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.02.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2007.02.001

1 reference

31 January 2017

1 reference